Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • Pathology Captures
Subscribe
Subscribe

False

The Pathologist / Issues / 2015 / Mar / Going For Gold
Genetics and epigenetics Bioinformatics Omics

Going For Gold

Genomic processor is named innovation of the year

By Roisin McGuigan 03/03/2015 1 min read

Share

After careful scrutiny by a panel of judges, The Scientist magazine has announced its top 10 life science innovations of 2014 (1) and… genomics came out on top. In fact, technologies used in sequencing snagged the top five positions on the list (Table 1). The number one spot was taken by the DRAGEN Bio-IT processor from US-based company, Edico Genome.

The idea behind the processor is to shrink the effort needed for genomic analysis – instead of a group of servers, DRAGEN can store and analyze data on a small card which can be installed on a server as small as a desktop computer. According to CEO Pieter van Rooyen, it can also drastically reduce analysis time. “The card is available on a pre-configured server that can be easily integrated into a next generation sequencing (NGS) bioinformatics pipeline,” he says. “The processor is loaded with optimized algorithms for NGS analysis including decompression, mapping, aligning, sorting, and haplotype variant calling.

0215-207-main-450

This can reduce the time it takes to analyze a whole human genome at 30X coverage from 24 hours to just 24 minutes. It could also reduce the costs of storage and IT infrastructure,” he explains. So what are Edico’s plans for DRAGEN? “Sequenom is our first customer, and our technology is also being used by the University of California, San Diego, US. We only began selling DRAGEN a few months ago, but we are talking with a number of potential partners and customers – ranging from small startups to well established companies, to academic institutions and even government agencies. Potential future areas include clinical genomics, especially cancer genomics, and non-invasive prenatal testing, which I think will grow tremendously in coming years.” Looking ahead, Edico want to extend the platform beyond the genome, exome and panel workflows they currently offer, to include RNA-seq, cancer, transcriptome, methylome and microbiome analysis. “We are honored and humbled to have been named the number one innovation of 2014 – it’s a true testament to the hard work and dedication of our team,” says van Rooyen.

Newsletters

Receive the latest pathologist news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

References

  1. The Scientist, “Top 10 Innovations 2014”, (2014). Available at: http://bit.ly/12jXGIZ. Accessed February 11, 2015.

About the Author(s)

Roisin McGuigan

I have an extensive academic background in the life sciences, having studied forensic biology and human medical genetics in my time at Strathclyde and Glasgow Universities. My research, data presentation and bioinformatics skills plus my ‘wet lab’ experience have been a superb grounding for my role as an Associate Editor at Texere Publishing. The job allows me to utilize my hard-learned academic skills and experience in my current position within an exciting and contemporary publishing company.

More Articles by Roisin McGuigan

Explore More in Pathology

Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement

Recommended

False

Related Content

Breathing New Life into Diagnostics
Genetics and epigenetics
Breathing New Life into Diagnostics

January 22, 2024

6 min read

Jonathan Edgeworth on how metagenomics could transform testing for respiratory infections

Molecular Spectacular
Genetics and epigenetics
Molecular Spectacular

January 8, 2024

1 min read

A look at last year’s most interesting molecular pathology stories

Redefining Diagnostic Reference Standards
Genetics and epigenetics
Redefining Diagnostic Reference Standards

January 3, 2022

1 min read

Find out what Horizon Discovery’s diagnostic reference standards can do for your workflow

Defining the Next Generation of NGS
Genetics and epigenetics
Defining the Next Generation of NGS

December 31, 2021

1 min read

Overcoming challenges of the typical NGS workflow with the Ion Torrent™ Genexus™ System

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.